Emergent BioSolutions Inc. (EBS)
NYSE
Healthcare
Biotechnology
$4.84
▼ -8.85%
Market Cap
$249.7M
Sector
Healthcare
Industry
Biotechnology
Beta
2.34
52-Wk Range
4.81-14.06
CEO
Joseph C. Papa Jr.
Country
US
Currency
USD
Emergent BioSolutions Inc. is a life sciences company dedicated to providing vital preparedness and response solutions for a wide range of public health threats (PHTs) across the United States. These threats encompass accidental, deliberate, and naturally occurring events, including chemical, biological, radiological, nuclear, and explosives (CBRNE) incidents, emerging infectious diseases, travel-related health risks, and acute emergency care situations. The company's current product portfolio features essential vaccines and treatments such as BioThrax for anthrax and ACAM2000 for smallpox. It…
Open full interactive analysis & DCF →